ArticleJTCVS techniques2025
Subxiphoid robotic thymectomy for anterior mediastinal tumors located in cervical region.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Thymomas sometimes are located in the cervical region, and strategies are needed to safely remove these tumors. The purpose of this study was to evaluate the feasibility and safety of subxiphoid robotic thymectomy (SRT) for anterior mediastinal tumors located in cervical region. Methods: This was a retrospective database review of patients who underwent SRT from January 2011 to April 2024. Of the 81 patients who underwent SRT for anterior mediastinal tumors, 79 patients were included, excluding 2 patients who underwent reconstruction using artificial blood vessels. Results: In total, 41 patients in whom part of the tumor was located above or in contact with the innominate vein were classified as group A, and 38 patients in which the tumor was located caudal to the innominate vein were classified as group B. The patients in group A were significantly younger (median, 54 years vs 63 years; Conclusions: SRT, which enables full visualization of the innominate vein from the midline view, may offer increased safety for complicated thymectomies, including those requiring combined resection of the innominate vein, and may demonstrate safety comparable with that of procedures performed for cases caudal to the innominate vein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.